Efficacy of Rupatadine 5, 10 and 20 Mg in Chronic Idiopathic Urticaria
Status:
Terminated
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of rupatadine for the
treatment of CIU symptoms.To assess the clinical efficacy of a dose ranging of rupatadine
fumarate (5mg, 10mg, and 20 mg) compared with placebo for relief of CIU symptoms.